Guillaume Couillard

Guillaume Couillard is the Director General of the Patented Medicine Prices Review Board (PMPRB) in Canada. He plays a pivotal role in overseeing the regulatory framework that monitors and evaluates pharmaceutical pricing in the Canadian market. With a focus on transparency and efficiency, Couillard has been instrumental in implementing new guidelines that streamline the process of drug price assessment, aiming to protect Canadian consumers from excessive pricing while encouraging innovation in the pharmaceutical industry.